Literature DB >> 10222436

Neuroblastoma as a neurobiological disease.

N F Schor1.   

Abstract

While neuroscientists are often involved in the assessment and care of patients with central nervous system tumors, they are only rarely involved in the case of peripheral nervous system neoplasia. Neuroblastoma is a childhood tumor of the primitive sympathetic nervous system. It is at once one of the most common and one of the most deadly tumors of childhood. The prognosis for children with this tumor has not changed in the past two decades. Clearly, a fresh approach to neuroblastoma is needed. The neuroscientist has much to add to our understanding and treatment of neuroblastoma and its sequelae. Conversely, neuroblastoma has much to teach us regarding the normal development of the neural crest and the aberrant loss of neurons in this lineage. A neuroscientist's approach to neuroblastoma, its biology and clinical features, is presented herein.

Entities:  

Mesh:

Year:  1999        PMID: 10222436     DOI: 10.1023/a:1006171406740

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  68 in total

1.  Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy.

Authors:  N F Tabachnik Schor
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

3.  Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes.

Authors:  H F Furneaux; L Reich; J B Posner
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

4.  Investigations on the neural crest. Methodological aspects and recent advances.

Authors:  N M Le Douarin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  Hearing loss as an initial symptom of the opsoclonus-myoclonus syndrome.

Authors:  N L Rosenberg
Journal:  Arch Neurol       Date:  1984-09

Review 6.  Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease.

Authors:  H A Gelbard; R M Boustany; N F Schor
Journal:  Pediatr Neurol       Date:  1997-02       Impact factor: 3.372

7.  Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.

Authors:  A Jacobs; M Delree; B Desprechins; J Otten; A Ferster; M H Jonckheer; J Mertens; H R Ham; A Piepsz
Journal:  Pediatr Radiol       Date:  1990

8.  Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor.

Authors:  M Falcione; K D Milligan; M C Schwartz; N F Schor
Journal:  Biochem Pharmacol       Date:  1993-08-17       Impact factor: 5.858

Review 9.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

10.  Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line.

Authors:  E Tiffany-Castiglioni; R P Saneto; P H Proctor; J R Perez-Polo
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

View more
  13 in total

1.  Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells.

Authors:  Chen Feng; Tianyou Wang; Ruihong Tang; Jianwen Wang; Hui Long; Xiaoning Gao; Suoqin Tang
Journal:  Pediatr Surg Int       Date:  2010-08-25       Impact factor: 1.827

Review 2.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 3.  Pharmacologic management of high-risk neuroblastoma in children.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

4.  Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells.

Authors:  Manrong Jiang; Kejin Zhu; Jose Grenet; Jill M Lahti
Journal:  Biochim Biophys Acta       Date:  2008-03-10

5.  Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.

Authors:  Yuan Li; Baofu Zhang; Hongwei Zhang; Xiaoyu Zhu; Dongchuan Feng; Deyong Zhang; Baobiao Zhuo; Liantao Li; Junnian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

6.  Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo.

Authors:  Baobiao Zhuo; Rong Wang; Yiyu Yin; Hongwei Zhang; Tongsheng Ma; Fengli Liu; Hui Cao; Yingchun Shi
Journal:  Tumour Biol       Date:  2013-04-23

Review 7.  The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Authors:  Nancy Ratner; Garrett M Brodeur; Russell C Dale; Nina F Schor
Journal:  Ann Neurol       Date:  2016-04-30       Impact factor: 10.422

8.  Leucine to proline substitution by SNP at position 197 in Caspase-9 gene expression leads to neuroblastoma: a bioinformatics analysis.

Authors:  Arpita Kundu; Susmita Bag; Sudha Ramaiah; Anand Anbarasu
Journal:  3 Biotech       Date:  2012-09-18       Impact factor: 2.406

9.  Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model.

Authors:  Qiqi Zhu; Chen Feng; Weiwei Liao; Yan Zhang; Suoqin Tang
Journal:  Cancer Cell Int       Date:  2013-06-27       Impact factor: 5.722

10.  Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis.

Authors:  Yao Cheng; Dong-mei Diao; Hao Zhang; Yong-Chun Song; Cheng-Xue Dang
Journal:  Int J Med Sci       Date:  2013-03-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.